会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Total Synthesis of Myriaporones
    • 全氟化氢的合成
    • US20080269511A2
    • 2008-10-30
    • US10523172
    • 2005-09-01
    • Carlos del Pozo LosadaAndres Francesch SollosoCarmen Cuevas MarchanteMarta Perez Alvarez
    • Carlos del Pozo LosadaAndres Francesch SollosoCarmen Cuevas MarchanteMarta Perez Alvarez
    • C07D407/02C07D303/34
    • C07D407/06A61K31/35C07D493/08Y02P20/55
    • Compounds of the general formula (I) or a pharmaceutically acceptable salt, derivative, prodrug or stereoisomer thereof are provided: wherein the substituent groups defined by R are each independently selected from the group consisting of H, SiR′3, SOR′, SO2X, C(═O)R′, C(═O)OR′, C(═O)NR′, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, aryl, heteroaryl or aralkyl; the group R′ is selected from substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, aminoalkyl, aryl, aralkyl and heterocyclic groups; and the group R″ is selected from the group consisting of H, OH, OR′, OCOR′, SH, SR′, SOR′, SO2R′, NO2, NH2, NHR′, N(R′)2, NHCOR′, N(COR′)2, NHSO2R′, CN, halogen, C(═O)H, C(═O)R′, CO2H, CO2R′, CH2OR, substituted or unsubstituted alkyl, substituted or unsubstituted haloalkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkylidene, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl and substituted or unsubstituted heteroaromatic; with the proviso that the compound is not compound 1, 3 or 4 of U.S. Pat. No. 5,514,708. The compounds have antitumour activity. A synthetic route is also provided.
    • 提供了通式(I)化合物或其药学上可接受的盐,衍生物,前药或立体异构体:其中由R定义的取代基各自独立地选自H,SiR'3 (O)OR',C( - )NR',取代或未取代的烷基,取代或未取代的链烯基, 取代或未取代的炔基,芳基,杂芳基或芳烷基; 基团R'选自取代或未取代的烷基,取代或未取代的烯基,取代或未取代的炔基,氨基烷基,芳基,芳烷基和杂环基; 并且基团R“选自H,OH,OR',OCOR',SH,SR',SOR',SO 2 R',NO 2, NH 2,NH 2,NH 2,NH 2,NH 2,NH 2,NH 2,NH 3, R 2,R 2,R 2,R 2,R 2,R 2,R 2,R 3, 取代或未取代的烷基,取代或未取代的烷基,取代或未取代的亚烷基,取代或未取代的炔基,取代或未取代的芳基,取代或未取代的芳烷基和取代或未取代的芳烷基 杂芳族; 条件是该化合物不是美国专利号4,3,3或4的化合物1,3或4。 第5,514,708号。 该化合物具有抗肿瘤活性。 还提供了合成路线。